• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

    14.09 +0.53 (+3.91%)
    Streaming Delayed Price Updated: 11:04 AM EDT, Mar 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Tonix Pharmaceuticals Holding Corp. - Common Stock

    < Previous 1 2 3 4 5 Next >
    BioMedNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q4 and Full-Year 2025 Results, Highlights Launch of TONMYA(TM)
    Via Investor Brand Network
    News headline image
    Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
    Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents TONMYA Data at International Fibromyalgia Congress
    Via Investor Brand Network
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Announces Peer-Reviewed Publication Highlighting Pharmacokinetics of TONMYA(TM) Sublingual Tablets
    Via Investor Brand Network
    BioMedNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present Tonmya Data at 2026 AAPM PainConnect Annual Meeting
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present Tonmya Data at 2026 AAPM PainConnect Annual Meeting
    Via Investor Brand Network
    TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Approved to Transfer Listing to Nasdaq Global Select Market
    Via Investor Brand Network
    BioMedNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Participate in March Investor Conferences
    Via Investor Brand Network
    TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Phase 3 Data for TONMYA(TM) in Fibromyalgia at Non-Opioid Pain Summit
    Via Investor Brand Network
    BioMedNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at January Investor Conferences
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at January Investor Conferences
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Provides Update on TNX-4800 Lyme Disease Prophylaxis Program
    Via Investor Brand Network
    TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Announces $20 Million Registered Direct Offering with Point72
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Irina Ishak as General Counsel
    Via Investor Brand Network
    News headline image
    Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations
    From BioMedWire
    Via GlobeNewswire
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances TNX-2900 for Prader-Willi Syndrome Into Phase 2 Trial
    Via Investor Brand Network
    Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
    Via Investor Brand Network
    Topics Government
    News headline image
    Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
    EQNX::TICKER_START (NASDAQ:SNGX),(NASDAQ:FOLD),(NASDAQ:TNXP),(NASDAQ:CTOR),(NASDAQ:AMGN) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Topics Government
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present TNX-801 Mpox Vaccine Data at Vaccine Congress 2025
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Publishes Preclinical Data Supporting TNX-1700 as Immunotherapy Enhancer in Gastric Cancer
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Added to Russell 3000 and Russell 2000 Indexes
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Phase 3 Data on Fibromyalgia Drug at EULAR 2025
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Jim Hunter to Board of Directors
    Via Investor Brand Network
    TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at 2025 BIO International Convention
    Via Investor Brand Network
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at EULAR 2025 in Barcelona
    Via Investor Brand Network
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO Joins A.G.P. Healthcare Showcase Fireside Chat
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Doses First Patient in DoD-Backed OASIS Trial for Acute Stress Reaction
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Joseph Hand as General Counsel and EVP of Operations
    Via Investor Brand Network
    TechMediaBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Prepares for Potential Fibromyalgia Drug Approval, Reports Q1 Results
    Via Investor Brand Network
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.